In addition, IL-2, together with transforming growth factor , plays a role in the maintenance and activation of CD4+CD25+Foxp3+regulatory T cells, which have been implicated in suppressing immunity to malaria (9,20,35,42,43). and were unable to induce NK cell IFN- production. Coculture of DCs and NK cells exhibited that DC-mediated NK cell activation required IL-12 and, to a lesser extent, IL-2, as well as cell-cell contact. In turn, Rabbit polyclonal to ACBD5 NK cells from infected WT mice enhanced DC maturation, IL-12 production, and KRas G12C inhibitor 3 priming of CD4+T-cell proliferation and IFN- secretion. Infected WT mice depleted of NK cells, which exhibit increased parasitemia, experienced impaired DC maturation and DC-induced CD4+Th1 cell priming. These findings show that DC-NK cell reciprocal cross talk is critical for control and quick resolution ofP. chabaudiAS contamination and provide in vivo evidence for the importance of this conversation in IFN–dependent immunity to malaria. Studies performed with humans and with mice indicate that NK cells are a crucial and early source of gamma interferon (IFN-) during blood-stage malaria contamination (3,4,12,28). Consistent with findings with other infectious brokers, tumors, and inflammatory diseases, optimal NK cell IFN- production during malaria requires accessory cells (10,11). Newman et al. (29) exhibited that IFN- production by human NK cells in response toPlasmodium falciparum-infected reddish blood cells (iRBC) occurs only following multiple contact-dependent and cytokine-mediated signals derived from myeloid dendritic cells (DCs) and monocytes. The proinflammatory cytokines type 1 IFN, interleukin 2 (IL-2), IL-12, and to a lesser extent IL-18, but not IL-15, were found to be required for NK cell activation, while transforming growth factor suppressed NK cell activation (3,4,29). Reciprocal regulation of accessory cell maturation by NK cells was observed to be much like findings of bidirectional interactions between NK cells and accessory cells in other systems (10,11,16,17). On the other hand, Baratin et al. (6) reported that human monocytes, not DCs, are required to induce NK cell IFN- production in vitro in response toP. KRas G12C inhibitor 3 falciparumiRBC. That study also implicated multiple accessory cell-derived signals, including IL-12 and IL-18, as requirements for NK cell IFN- production in response to iRBC, and an IL-18R/MyD88-dependent pathway was demonstrated to be necessary for NK cell activation (6). Together, these studies indicate that NK cell activation following exposure to iRBC in vitro requires an accessory cell, but the identity of this cell is usually unclear, as is the relevance of interactions between NK cells and accessory cells to the in vivo control of blood-stage malaria. Given the importance of the innate immune response in shaping adaptive immunity, a better understanding of the cellular mechanisms and cytokines involved in cross talk between NK cells and accessory cells during malaria is required. Control and resolution ofPlasmodium chabaudiAS contamination in mice critically requires IL-12-dependent IFN- production by NK cells and CD4+T cells (37). During acuteP. chabaudiAS contamination in resistant C57BL/6 (B6) mice, NK cells, macrophages, and DCs rapidly accumulate and expand KRas G12C inhibitor 3 in the spleen, where they undergo maturation and functional activation in response to iRBC captured in the spleen for removal (24,25,28,32,46). Notably, CD11c+DCs migrate from your marginal zone to the CD4+T-cell-rich periarteriolar lymphoid sheaths during early contamination, while macrophages expand and remain in the reddish pulp (25). Contrary to reports of functional impairment of DCs during lethal infections due toPlasmodium berghei,P. yoeliiYM, orP. vinckei, the in vitro or in vivo exposure of bone marrow-derived or splenic DCs toP. chabaudiAS iRBC results in upregulation of major histocompatibility complex class II and costimulatory molecule expression; production of the proinflammatory cytokines IL-12, IFN-, tumor necrosis factor alpha (TNF-), and IL-6; and the ability to stimulate nave CD4+T-cell proliferation and IFN- production (23-25,34,45,46). In contrast, splenic macrophages fromP. chabaudiAS-infected mice suppress T-cell proliferation and IL-2 production (1,33). Comparable findings concerning the ability of DCs to activate T cells as opposed to macrophage-mediated suppression of T-cell activation were reported in mice with a nonlethalP. yoeliiinfection (26,30). Together, these findings provide compelling evidence KRas G12C inhibitor 3 that DCs play an important role in innate immunity during blood-stage malaria and shape an adaptive type 1 immune response necessary for control and quick resolution of contamination. In the present study, we investigated the requirements for reciprocal activation of DCs and NK cells leading to priming of CD4+Th1 cell responses inP. chabaudiAS-infected mice using in vitro and in vivo methods. DC maturation, cytokine production, and the ability to activate NK cell IFN- production in vitro were compared among wild-type (WT) B6, IL-15/, and IL-12p40/mice.
Recent Posts
- The membrane fraction was pelleted at 100 000 gfor 1 h and washed twice with 1msodium carbonate ahead of solubilization with 1% SDS in TBS at 70C for 15 min
- Discussion == In this scholarly study, particle detection is conducted in controlled lab conditions, such as for example placid water and dark ambient illumination, to reduce sound from water turbulence and spurious ambient light sources and, consequently, to isolate the fluorescence emissions
- Introduction == Both single-molecules detection (SMD) methods and microfluidic techniques have been increasingly applied to biological systems over the last ten years
- Sections D present immunoblot evaluation from the IP and WCL from theE
- 4
Recent Comments
Archives
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- June 2025
- May 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
Categories
- Orexin Receptors
- Orexin, Non-Selective
- Orexin1 Receptors
- Orexin2 Receptors
- Organic Anion Transporting Polypeptide
- ORL1 Receptors
- Ornithine Decarboxylase
- Orphan 7-TM Receptors
- Orphan 7-Transmembrane Receptors
- Orphan G-Protein-Coupled Receptors
- Orphan GPCRs
- OT Receptors
- Other Acetylcholine
- Other Adenosine
- Other Apoptosis
- Other ATPases
- Other Calcium Channels
- Other Cannabinoids
- Other Channel Modulators
- Other Dehydrogenases
- Other Hydrolases
- Other Ion Pumps/Transporters
- Other Kinases
- Other MAPK
- Other Nitric Oxide
- Other Nuclear Receptors
- Other Oxygenases/Oxidases
- Other Peptide Receptors
- Other Pharmacology
- Other Product Types
- Other Proteases
- Other Reductases
- Other RTKs
- Other Synthases/Synthetases
- Other Tachykinin
- Other Transcription Factors
- Other Transferases
- Other Wnt Signaling
- OX1 Receptors
- OXE Receptors
- Oxidative Phosphorylation
- Oxoeicosanoid receptors
- Oxygenases/Oxidases
- Oxytocin Receptors
- P-Glycoprotein
- P-Selectin
- P-Type ATPase
- P-Type Calcium Channels
- p14ARF
- p160ROCK
- P2X Receptors
- P2Y Receptors
- p38 MAPK
- p53
- p56lck
- p60c-src
- p70 S6K
- p75
- p90 Ribosomal S6 Kinase
- PAC1 Receptors
- PACAP Receptors
- PAF Receptors
- PAO
- PAR Receptors
- Parathyroid Hormone Receptors
- PARP
- PC-PLC
- PDE
- PDGFR
- PDK1
- PDPK1
- Peptide Receptor, Other
- Peptide Receptors
- Peroxisome-Proliferating Receptors
- PGF
- PGI2
- Phosphatases
- Phosphodiesterases
- Phosphoinositide 3-Kinase
- Phosphoinositide-Specific Phospholipase C
- Phospholipase A
- Phospholipase C
- Phospholipases
- Phosphorylases
- Photolysis
- PI 3-Kinase
- PI 3-Kinase/Akt Signaling
- PI-PLC
- PI3K
- Pim Kinase
- Pim-1
- PIP2
- Pituitary Adenylate Cyclase Activating Peptide Receptors
- PKA
- PKB
- PKC
- PKD
- PKG
- PKM
- PKMTs
- PLA
- Plasmin
- Platelet Derived Growth Factor Receptors
- Platelet-Activating Factor (PAF) Receptors
- Uncategorized